BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Jung Y, Lee MK, Puri P, Koo BK, Joo SK, Jang SY, Lee DH, Jung YJ, Kim BG, Lee KL, Park TS, Kang KT, Ryu DH, Kang SW, Kim D, Oh S, Kim W, Hwang GS. Circulating lipidomic alterations in obese and non-obese subjects with non-alcoholic fatty liver disease. Aliment Pharmacol Ther 2020;52:1603-14. [PMID: 32892365 DOI: 10.1111/apt.16066] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Nakashima A, Kato K, Ohkido I, Yokoo T. Role and Treatment of Insulin Resistance in Patients with Chronic Kidney Disease: A Review. Nutrients 2021;13:4349. [PMID: 34959901 DOI: 10.3390/nu13124349] [Reference Citation Analysis]
2 Dai W, Zhang Z, Zhao S. The Risk of Type 2 Diabetes and Coronary Artery Disease in Non-obese Patients With Non-alcoholic Fatty Liver Disease: A Cohort Study. Front Cardiovasc Med 2021;8:680664. [PMID: 34490362 DOI: 10.3389/fcvm.2021.680664] [Reference Citation Analysis]
3 Yao M, Li L, Huang M, Tan Y, Shang Y, Meng X, Pang Y, Xu H, Zhao X, Lei W, Chang Y, Wang Y, Zhang D, Zhang B, Li Y. Sanye Tablet Ameliorates Insulin Resistance and Dysregulated Lipid Metabolism in High-Fat Diet-Induced Obese Mice. Front Pharmacol 2021;12:713750. [PMID: 34658856 DOI: 10.3389/fphar.2021.713750] [Reference Citation Analysis]